SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-139238
Filing Date
2024-12-20
Accepted
2024-12-20 20:30:25
Documents
2
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1606
2 EX-24.1 ck0001697532-ex24_1.htm EX-24.1 8934
  Complete submission text file 0000950170-24-139238.txt   12149
Mailing Address DENDREON CORPORATION 1301 2ND AVENUE SEATTLE WA 98101
Business Address
JOHNSON JOHN (Reporting) CIK: 0001410781 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38898 | Film No.: 241569461

Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Issuer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)